Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration

Acute Cholecystitis Associated With the Use of Glucagon-Like Peptide-1 Receptor Agonists Reported to the US Food and Drug Administration

This case series identifies cases reported in the US Food and Drug Administration Adverse Event Reporting System of acute cholecystitis associated with use of glucagon-like peptide-1 receptor agonists that did not have gallbladder disease warnings in their labeling.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Archives of internal medicine (1960) 2022-10, Vol.182 (10), p.1104-1106
Hauptverfasser: Woronow, Daniel, Chamberlain, Christine, Niak, Ali, Avigan, Mark, Houstoun, Monika, Kortepeter, Cindy
Format: Artikel
Sprache:eng
Schlagworte:
Antagonist drugs
Descriptive labeling
Gallbladder diseases
Letters
Online First
Research Letter
Side effects
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:This case series identifies cases reported in the US Food and Drug Administration Adverse Event Reporting System of acute cholecystitis associated with use of glucagon-like peptide-1 receptor agonists that did not have gallbladder disease warnings in their labeling.
ISSN:2168-6106
2168-6114
DOI:10.1001/jamainternmed.2022.3810